Form 4: Conmed Corp Director Brian Concannon Reports Transaction in Company Stock
SEC Form 4 Filing
Director Brian Concannon reports the acquisition and disposal of Conmed Corp stock and derivative securities.
Summary
- On May 31, 2024, Brian Concannon, a director of Conmed Corp, reported a transaction involving common stock.
- He acquired 302 shares of common stock at $0.
- Following the transaction, Concannon directly owns 9,637 shares of Conmed Corp.
- On June 3, 2024, Concannon acquired 5,503 options to purchase common stock with an exercise price of $77.18, expiring on June 3, 2034.
- These options vest 100% after one year.
- Concannon also acquired 479 restricted stock units (RSUs) on June 3, 2024, which vest 100% after one year and represent a contingent right to receive one share of common stock.
- These RSUs expire on June 3, 2034.
- The transactions were reported on Form 4, filed with the SEC on June 5, 2024.
- Thomas Fistek signed the report on Brian Concannon's behalf, by Power of Attorney.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of options and RSUs could be interpreted as a slightly positive signal, but it's not definitive.
Positives
- The acquisition of stock options and RSUs by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The vesting schedules of the options and RSUs indicate a continued relationship between the director and the company over the next year.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company.
Comparison to Industry Standards
- Director compensation packages often include stock options and RSUs to align their interests with those of shareholders.
- Vesting schedules of one year are common in the industry to incentivize long-term commitment.
Stakeholder Impact
- Shareholders may view the insider transactions as a signal of management's confidence in the company.
- The transactions have no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2023-09-13 | Date of Limited Power of Attorney execution by Brian P. Concannon. |
| 2024-05-31 | Date of common stock transaction. |
| 2024-05-31 | Date of RSU transaction. |
| 2024-06-03 | Date of options to purchase common stock transaction. |
| 2024-06-03 | Date of RSU transaction. |
| 2024-06-05 | Date Form 4 was signed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.